These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 23507584)
1. Mitochondrial DNA mutations in exhaled breath condensate of patients with lung cancer. Yang Ai SS; Hsu K; Herbert C; Cheng Z; Hunt J; Lewis CR; Thomas PS Respir Med; 2013 Jun; 107(6):911-8. PubMed ID: 23507584 [TBL] [Abstract][Full Text] [Related]
2. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer. Carpagnano GE; Foschino-Barbaro MP; Mulé G; Resta O; Tommasi S; Mangia A; Carpagnano F; Stea G; Susca A; Di Gioia G; De Lena M; Paradiso A Am J Respir Crit Care Med; 2005 Sep; 172(6):738-44. PubMed ID: 15947287 [TBL] [Abstract][Full Text] [Related]
3. Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients. Gessner C; Kuhn H; Toepfer K; Hammerschmidt S; Schauer J; Wirtz H Lung Cancer; 2004 Feb; 43(2):215-22. PubMed ID: 14739043 [TBL] [Abstract][Full Text] [Related]
4. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer. Carpagnano GE; Foschino-Barbaro MP; Spanevello A; Resta O; Carpagnano F; Mulé G; Pinto R; Tommasi S; Paradiso A Am J Respir Crit Care Med; 2008 Feb; 177(3):337-41. PubMed ID: 17962633 [TBL] [Abstract][Full Text] [Related]
6. Exhaled HPV infection in lung cancer: role of MA at 3p. Carpagnano GE; Lacedonia D; Crisetti E; Palladino GP; Saliani V; Zoppo LD; Antonetti R; Natalicchio I; Foschino-Barbaro MP Arch Med Res; 2014 Jul; 45(5):383-7. PubMed ID: 24962429 [TBL] [Abstract][Full Text] [Related]
7. Elevated levels of oxidative stress markers in exhaled breath condensate. Chan HP; Tran V; Lewis C; Thomas PS J Thorac Oncol; 2009 Feb; 4(2):172-8. PubMed ID: 19179892 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients. Carpagnano GE; Spanevello A; Carpagnano F; Palladino GP; Prato R; Martinelli D; Digioia G; Foschino-Barbaro MP Lung Cancer; 2009 Jun; 64(3):334-40. PubMed ID: 18995925 [TBL] [Abstract][Full Text] [Related]
9. Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer. Xiao P; Chen JR; Zhou F; Lu CX; Yang Q; Tao GH; Tao YJ; Chen JL Lung Cancer; 2014 Jan; 83(1):56-60. PubMed ID: 24268095 [TBL] [Abstract][Full Text] [Related]
10. Intratumor heterogeneity and tissue distribution of KRAS mutation in non-small cell lung cancer: implications for detection of mutated KRAS oncogene in exhaled breath condensate. Kordiak J; Szemraj J; Grabska-Kobylecka I; Bialasiewicz P; Braun M; Kordek R; Nowak D J Cancer Res Clin Oncol; 2019 Jan; 145(1):241-251. PubMed ID: 30368666 [TBL] [Abstract][Full Text] [Related]
11. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients. Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325 [TBL] [Abstract][Full Text] [Related]
14. Comparison study of the performance of the QIAGEN EGFR RGQ and EGFR pyro assays for mutation analysis in non-small cell lung cancer. Cushman-Vokoun AM; Crowley AM; Rapp SA; Greiner TC Am J Clin Pathol; 2013 Jul; 140(1):7-19. PubMed ID: 23765529 [TBL] [Abstract][Full Text] [Related]
15. Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer. Kimura H; Kasahara K; Kawaishi M; Kunitoh H; Tamura T; Holloway B; Nishio K Clin Cancer Res; 2006 Jul; 12(13):3915-21. PubMed ID: 16818687 [TBL] [Abstract][Full Text] [Related]
16. Exhaled breath condensate pH in patients with lung cancer. Antus B; Barta I Lung Cancer; 2012 Feb; 75(2):178-80. PubMed ID: 21831475 [TBL] [Abstract][Full Text] [Related]
17. Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers. Hillas G; Kostikas K; Mantzouranis K; Bessa V; Kontogianni K; Papadaki G; Papiris S; Alchanatis M; Loukides S; Bakakos P Respirology; 2011 Jul; 16(5):811-8. PubMed ID: 21545371 [TBL] [Abstract][Full Text] [Related]
18. Detection of activated K-ras in non-small cell lung cancer by membrane array: a comparison with direct sequencing. Chong IW; Chang MY; Sheu CC; Wang CY; Hwang JJ; Huang MS; Lin SR Oncol Rep; 2007 Jul; 18(1):17-24. PubMed ID: 17549340 [TBL] [Abstract][Full Text] [Related]
19. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413 [TBL] [Abstract][Full Text] [Related]
20. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]